Fred Hutchinson Cancer Center
Overview
The Fred Hutchinson Cancer Center is a leading cancer research institution dedicated to improving the prevention and treatment of cancer and related diseases. Known for its cutting-edge research and innovative clinical trials, the center strives to transform the future of cancer care.
Therapeutic areas
API / Drug Master Files
Fred Hutchinson Cancer Center holds 0 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- B9E9SCFV4-SA FUSION PROTEINInactive2015-10-19
- MANUFACTURE AND QUALITY CONTROL OF THE BC8-DOTA MONOCLONAL ANTIBODY CONJUGATE (BC8-DOTA)Inactive2011-03-01
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Fred Hutchinson Cancer Center in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Fred Hutchinson Cancer Center? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.